Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.
Identifieur interne : 004430 ( PubMed/Checkpoint ); précédent : 004429; suivant : 004431Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.
Auteurs : D A Wrone [États-Unis] ; K K Tanabe ; A B Cosimi ; M A Gadd ; W W Souba ; A J SoberSource :
- Archives of dermatology [ 0003-987X ] ; 2000.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Mélanome, Noeuds lymphatiques, Tumeurs cutanées.
- diagnostic : Lymphoedème.
- effets indésirables : Biopsie.
- étiologie : Lymphoedème.
- Adulte, Adulte d'âge moyen, Facteurs temps, Femelle, Humains, Mâle, Mélanome, Tumeurs cutanées.
English descriptors
- KwdEn :
- MESH :
- adverse effects : Biopsy.
- complications : Melanoma, Skin Neoplasms.
- diagnosis : Lymphedema.
- etiology : Lymphedema.
- pathology : Lymph Nodes, Melanoma, Skin Neoplasms.
- Adult, Female, Humans, Male, Middle Aged, Time Factors.
Abstract
Sentinel lymph node (SLN) biopsy has rapidly become the procedure of choice for assessing the lymph node status of patients with 1992 American Joint Committee on Cancer stages I and II melanoma. The procedure was designed to be less invasive and, therefore, less likely to cause complications than a complete lymph node dissection. To our knowledge, this is the first report in the literature documenting extremity lymphedema following SLN biopsy.
PubMed: 10768650
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:10768650Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.</title>
<author><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D A" last="Wrone">D A Wrone</name>
<affiliation wicri:level="1"><nlm:affiliation>Massachusetts General Hospital Melanoma Center, Department of Dermatology, Massachusetts General Hospital, Boston 02114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Massachusetts General Hospital Melanoma Center, Department of Dermatology, Massachusetts General Hospital, Boston 02114</wicri:regionArea>
<placeName><settlement type="city">Boston</settlement>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K K" last="Tanabe">K K Tanabe</name>
</author>
<author><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A B" last="Cosimi">A B Cosimi</name>
</author>
<author><name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M A" last="Gadd">M A Gadd</name>
</author>
<author><name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W W" last="Souba">W W Souba</name>
</author>
<author><name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A J" last="Sober">A J Sober</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10768650</idno>
<idno type="pmid">10768650</idno>
<idno type="wicri:Area/PubMed/Corpus">004A89</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004A89</idno>
<idno type="wicri:Area/PubMed/Curation">004A89</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004A89</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004A89</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004A89</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.</title>
<author><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D A" last="Wrone">D A Wrone</name>
<affiliation wicri:level="1"><nlm:affiliation>Massachusetts General Hospital Melanoma Center, Department of Dermatology, Massachusetts General Hospital, Boston 02114, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Massachusetts General Hospital Melanoma Center, Department of Dermatology, Massachusetts General Hospital, Boston 02114</wicri:regionArea>
<placeName><settlement type="city">Boston</settlement>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K K" last="Tanabe">K K Tanabe</name>
</author>
<author><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A B" last="Cosimi">A B Cosimi</name>
</author>
<author><name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M A" last="Gadd">M A Gadd</name>
</author>
<author><name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W W" last="Souba">W W Souba</name>
</author>
<author><name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A J" last="Sober">A J Sober</name>
</author>
</analytic>
<series><title level="j">Archives of dermatology</title>
<idno type="ISSN">0003-987X</idno>
<imprint><date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Biopsy (adverse effects)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (etiology)</term>
<term>Male</term>
<term>Melanoma (complications)</term>
<term>Melanoma (pathology)</term>
<term>Middle Aged</term>
<term>Skin Neoplasms (complications)</term>
<term>Skin Neoplasms (pathology)</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Biopsie (effets indésirables)</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (étiologie)</term>
<term>Mâle</term>
<term>Mélanome ()</term>
<term>Mélanome (anatomopathologie)</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Tumeurs cutanées ()</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Biopsy</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Mélanome</term>
<term>Noeuds lymphatiques</term>
<term>Tumeurs cutanées</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymph Nodes</term>
<term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Mélanome</term>
<term>Tumeurs cutanées</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sentinel lymph node (SLN) biopsy has rapidly become the procedure of choice for assessing the lymph node status of patients with 1992 American Joint Committee on Cancer stages I and II melanoma. The procedure was designed to be less invasive and, therefore, less likely to cause complications than a complete lymph node dissection. To our knowledge, this is the first report in the literature documenting extremity lymphedema following SLN biopsy.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10768650</PMID>
<DateCreated><Year>2000</Year>
<Month>05</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted><Year>2000</Year>
<Month>05</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2008</Year>
<Month>03</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-987X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>136</Volume>
<Issue>4</Issue>
<PubDate><Year>2000</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Archives of dermatology</Title>
<ISOAbbreviation>Arch Dermatol</ISOAbbreviation>
</Journal>
<ArticleTitle>Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases.</ArticleTitle>
<Pagination><MedlinePgn>511-4</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Sentinel lymph node (SLN) biopsy has rapidly become the procedure of choice for assessing the lymph node status of patients with 1992 American Joint Committee on Cancer stages I and II melanoma. The procedure was designed to be less invasive and, therefore, less likely to cause complications than a complete lymph node dissection. To our knowledge, this is the first report in the literature documenting extremity lymphedema following SLN biopsy.</AbstractText>
<AbstractText Label="OBSERVATION" NlmCategory="METHODS">We report 5 cases of lymphedema after SLN biopsy in patients being routinely followed up after melanoma surgery at the Massachusetts General Hospital Melanoma Center, Boston. Three cases were mild, and 2 were moderate. Potential contributing causes of lymphedema were present in 4 patients and included the transient formation of hematomas and seromas, obesity, the possibility of occult metastatic melanoma, and the proximal extremity location of the primary melanoma excision. Four of the patients underwent an SLN biopsy at our institution. We used the total number of SLN procedures (N = 235) that we have performed to calculate a 1.7% baseline incidence of lymphedema after SLN biopsy.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sentinel lymph node biopsy can be complicated by mild and moderate degrees of lymphedema, with an incidence of at least 1.7%. Some patients may have contributing causes for lymphedema other than the SLN biopsy, but many of these causes are difficult to modify or avoid.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wrone</LastName>
<ForeName>D A</ForeName>
<Initials>DA</Initials>
<AffiliationInfo><Affiliation>Massachusetts General Hospital Melanoma Center, Department of Dermatology, Massachusetts General Hospital, Boston 02114, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tanabe</LastName>
<ForeName>K K</ForeName>
<Initials>KK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Cosimi</LastName>
<ForeName>A B</ForeName>
<Initials>AB</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gadd</LastName>
<ForeName>M A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Souba</LastName>
<ForeName>W W</ForeName>
<Initials>WW</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sober</LastName>
<ForeName>A J</ForeName>
<Initials>AJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Arch Dermatol</MedlineTA>
<NlmUniqueID>0372433</NlmUniqueID>
<ISSNLinking>0003-987X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008545" MajorTopicYN="N">Melanoma</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012878" MajorTopicYN="N">Skin Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>20</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2000</Year>
<Month>4</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2000</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2000</Year>
<Month>4</Month>
<Day>18</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">10768650</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Massachusetts</li>
</region>
<settlement><li>Boston</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Cosimi, A B" sort="Cosimi, A B" uniqKey="Cosimi A" first="A B" last="Cosimi">A B Cosimi</name>
<name sortKey="Gadd, M A" sort="Gadd, M A" uniqKey="Gadd M" first="M A" last="Gadd">M A Gadd</name>
<name sortKey="Sober, A J" sort="Sober, A J" uniqKey="Sober A" first="A J" last="Sober">A J Sober</name>
<name sortKey="Souba, W W" sort="Souba, W W" uniqKey="Souba W" first="W W" last="Souba">W W Souba</name>
<name sortKey="Tanabe, K K" sort="Tanabe, K K" uniqKey="Tanabe K" first="K K" last="Tanabe">K K Tanabe</name>
</noCountry>
<country name="États-Unis"><region name="Massachusetts"><name sortKey="Wrone, D A" sort="Wrone, D A" uniqKey="Wrone D" first="D A" last="Wrone">D A Wrone</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 004430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:10768650 |texte= Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:10768650" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |